| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA4827568 | B | Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control | Homo sapiens | 32 | single protein format | Scientific Literature | ||
| 2. | ALA4827569 | B | Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control | Homo sapiens | 32 | single protein format | Scientific Literature | ||
| 3. | ALA4827570 | B | Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control | Homo sapiens | 32 | single protein format | Scientific Literature | ||
| 4. | ALA4827571 | B | Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity by [gamma-33P]-ATP assay relative to control | Homo sapiens | 22 | single protein format | Scientific Literature | ||
| 5. | ALA4827572 | B | Inhibition of wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 9 | assay format | Scientific Literature | ||
| 6. | ALA4827573 | B | Inhibition of wild-type human partial length CAMKK1 (R65 to E414 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 9 | assay format | Scientific Literature | ||
| 7. | ALA4827575 | B | Inhibition of wild-type human partial length SGK (I60 to L431 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 2 | assay format | Scientific Literature | ||
| 8. | ALA4827576 | B | Inhibition of wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 3 | assay format | Scientific Literature | ||
| 9. | ALA4827582 | B | Inhibition of wild-type human partial length EPHB6 (Q634 to P948 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 3 | assay format | Scientific Literature | ||
| 10. | ALA4827589 | B | Inhibition of wild-type human partial length ICK (M1 to P314 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 2 | assay format | Scientific Literature | ||
| 11. | ALA4827606 | B | Inhibition of wild-type human full length CDK9 (M1 to F372 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature | ||
| 12. | ALA4827607 | B | Inhibition of wild-type human full length JNK1 (M1 to Q384 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature | ||
| 13. | ALA4827608 | B | Inhibition of wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature | ||
| 14. | ALA4827609 | B | Inhibition of wild-type human full length CDK2 (M1 to L298 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature | ||
| 15. | ALA4827610 | B | Inhibition of wild-type human full length CDK3 (M1 to H305 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature | ||
| 16. | ALA4827611 | B | Inhibition of wild-type human full length JNK2 (M1 to Q382 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature | ||
| 17. | ALA4827612 | B | Inhibition of wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature | ||
| 18. | ALA4827613 | B | Inhibition of wild-type human partial length CDKL5 (M1 to S337 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature | ||
| 19. | ALA4827614 | B | Inhibition of wild-type human partial length PIP5K2C (M1 to A421 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature | ||
| 20. | ALA4827615 | B | Inhibition of wild-type human partial length JNK3 (V28 to Q422 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature |
The page will load shortly, Thanks for your patience!